ALGORITMO SULLA IDROSADENITE SUPPURATIVA (HS)
* Per chi non visualizza in modo corretto l'immagine sopra riportiamo sotto la successione dei box dell'algoritmo.
- 2. Sospetta diagnosi di HS - MG
- 3. ( se NO punto 2)
Osservazione e valutazione da parte dello specialista territoriale
- 5. ( se SI punto 4)
Ruolo del Medico di Medicina Generale - 5 A - Rinforzo correzione fattori di rischio
- 5 B - Gestione condivisa della terapia, delle complicanze e degli effetti collaterali
- 5 C - Gestione del dolore
- 5 D - Gestione dei sintomi di suppurazione cutanea e delle recidive infiammatorie di malattia
- 6. ( se SI punto 4 )
Terapia e follow up
- 8. ( dal punto 6)
Risposta clinica/remissione
Riferimenti bibliografici
- 1. Zouboulis CC, del Marmol V, Mrowietz U, Prens EP, Tzellos T, Jemec GBE. Hidradenitis Suppurativa/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation. Dermatology. 2015;231(2):184-190.
- 2. Esmann S, Dufour DN, Jemec GBE. Questionnaire-based diagnosis of hidradenitis suppurativa: specificity, sensitivity and positive predictive value of specific diagnostic questions. Br J Dermatol. 2010;163(1):102-106.
- 3. D, Severac F, Freysz M, et al. The ABC of Hidradenitis Suppurativa: A Validated Glossary on how to Name Lesions. The ABC of Hidradenitis Suppurativa: A Validated Glossary on how to Name Lesions. Dermatology. 2016; 232(2):137-42.
- 4. Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015; 29(4):619-44.
- 5. Megna M, Bettoli V, Chimenti S, et al. Hidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti TNF-α agents. G Ital Dermatol Venereol. 2015 Dec;150(6):731-9.
- 6. Horváth B, Janse IC, Sibbald GR. Pain management in patients with hidradenitis suppurativa. J Am Acad Dermatol. 2015;73(5):S47-S51.
- 7. Tzellos T, Zouboulis CC, Gulliver W, Cohen a. D, Wolkenstein P, Jemec GBE. Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2015;173(5):1142-55.
- 8. Von Der Werth JM, Williams HC. The natural history of hidradenitis suppurativa. J Eur Acad Dermatology Venereol. 2000;14(5):389-392.
- 9. Dini V, Oranges T, Rotella L, Romanelli M. Hidradenitis Suppurativa and Wound Management. Int J Low Extrem Wounds. 2015;14(3):236-244.
- 10. Alavi A, Kirsner RS. Local wound care and topical management of hidradenitis suppurativa. J Am Acad Dermatol. 2015;73(5):S55-S61.
- 11. Bettoli V, Pasquinucci S, Caracciolo S, et al. The Hidradenitis suppurativa patient journey in Italy: current status , unmet needs and opportunities. J Eur Acad Dermatol Venereol. 2016 May 2. doi: 10.1111/jdv.13687. [Epub ahead of print]
- 12. Bettoli V, Join-Lambert O, Nassif A. Antibiotic Treatment of Hidradenitis Suppurativa. Dermatol Clin. 2016;34(1):81-89.
- 13. Lim ZV, Oon HH. Management of Hidradenitis Suppurativa in Patients with Metabolic Comorbidities. Ann Dermatol. 2016;28(2):147-151.
- 14. Danby FW. Diet in the prevention of hidradenitis suppurativa (acne inversa). J Am Acad Dermatol. 2015;73(5):S52-S54.
- 15. Sartorius K, Emtestam L, Jemec GBE, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol. 2009; 161(4):831-9
- 16. Danby FW, Hazen PG, Boer J. New and traditional surgical approaches to hidradenitis suppurativa. J Am Acad Dermatol. 2015;73(5 Suppl 1):S62-5